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Abstract:  Exposure  of  Escherichia  coli  to  a  subminimal  inhibitory  concentration  
(25%  below  MIC)  of  benzalkonium  chloride  (BC),  an  antimicrobial  membrane-active 
agent commonly used in medical and food-processing environments, resulted in cell death 
and changes in cell morphology (filamentation). A small subpopulation (1–5% of the initial 
population) survived and regained similar morphology and growth rate as non-exposed 
cells. This subpopulation maintained tolerance to BC after serial transfers in medium without 
BC. To withstand BC during regrowth the cells up regulated a drug efflux associated gene 
(the acrB gene, member of the AcrAB-TolC efflux system) and changed expression of 
outer membrane porin genes (ompFW) and several genes involved in protecting the cell 
from the osmotic- and oxidative stress. Cells pre-exposed to osmotic- and oxidative stress 
(sodium  chloride,  salicylic  acid  and  methyl  viologen)  showed  higher  tolerance  to  BC.  
A control and two selected isolates showing increased BC-tolerance after regrowth in BC 
was genome sequenced. No common point mutations were found in the BC- isolates but 
one  point  mutation  in  gene  rpsA  (Ribosomal  protein  S1)  was  observed  in  one  of  the 
isolates. The observed tolerance can therefore not solely be explained by the observed 
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point mutation. The results indicate that there are several different mechanisms responsible 
for the regrowth of a tolerant subpopulation in BC, both BC-specific and general stress 
responses,  and  that  sub-MIC  of  BC  may  select  for  phenotypic  variants  in  a  sensitive  
E. coli culture.  
Keywords: Escherichia coli; quaternary ammonium compounds; benzalkonium chloride; 
selection of subpopulation; efflux pump; osmotic and oxidative stress response 
 
1. Introduction  
Quaternary ammonium compounds (QACs), such as benzalkonium chloride (BC), are used in a 
wide range of applications such as disinfectants in food-processing and medical environments and as 
preservatives in pharmaceuticals and cosmetics. These antimicrobials are membrane-active agents with 
a target site predominantly at the cytoplasmic (inner) membrane and are also believed to damage the 
outer membrane of gram negative bacteria, thereby promoting their own uptake (for an overview,  
see [1,2]). The widespread use of these agents can lead to resistant bacteria, which may limit efficacy 
in pharmaceutical and cosmetic products or disinfection effects in food and medical applications [3]. 
There is  also the concern that resistance to disinfectants contributes to antibiotic resistance  [4–6], 
which  may  limit  treatment  options  for  microbial  infections.  There  are  several  reports  on  bacteria 
adapted  to  high  levels  of  BC  and  cross-resistance  to  other  antimicrobial  agents  [7–10].  The 
involvement of efflux pumps [8,11,12] and reduction in the outer membrane porin OmpF [11,13] have 
been suggested as  possible resistance mechanisms.  In addition,  changes  in  the LPS layer  [13,14], 
changes in fatty acid profiles [15,16] and changes in cell surface hydrophobicity [8,17] have been 
suggested to influence acquisition of resistance in gram negative bacteria. Previous research reports 
have mainly focused on strains adapted to high concentrations of BC after serial transfer in gradually 
higher concentrations of BC.  
In a previous study [9], we showed that after one transfer of E. coli in a BC-concentration 75% 
below MIC, the cells survived in higher concentrations in a bactericidal test. In the first transfer in the 
adaptation study, the MIC of BC doubled. Also, exposure of E. coli to salicylate, chenodeoycholate 
and methyl viologen increased the MIC of BC, indicating a role of general stress response systems. 
The mechanisms behind these responses were not determined, but in a later study, we found that  
E. coli cells exposed to BC-concentrations allowing growth had a remarkably different response from 
that of a range of other stress conditions [18]. While other stress factors (heat, cold, acid, alkali, salt, 
glycerol, ethanol and ethidium bromide) resulted in increased lag time and/or reduced growth rate, 
exposure to BC resulted in an initial killing of cells followed by growth at similar rates as non-stressed 
cells. Also, despite the major impact of BC on survival, the number of genes involved during regrowth 
was remarkably low compared to other stress factors. Only three genes (b1171, osmB and ykfE (ivy)) 
were identified as showing significantly different levels of expression (up regulated) for cells growing 
in the presence of BC. Gene b1171 has no known function, osmB encodes a lipoprotein and ykfE (ivy) 
encodes an inhibitor of C-lycozyme [19,20]. As far as we know, there are no publications on the 
mechanisms involved in the survival strategy of E coli exposed to subminimal inhibitory concentrations Int. J. Mol. Sci. 2012, 13  4103 
 
 
(sub-MICs) of BC and the following growth in the presence of BC. There are two recent studies of the 
effect of sub inhibitory concentrations of BC in Pseudomonas [21,22], one was over time in biofilm 
and the other was a long-term continuous culture subjected to increasing levels of BC, suggesting that 
sub-inhibitory concentrations of BC are sufficient to select for adapted variants.  
The aim of the current work was to investigate the survival mechanisms of E. coli growing in BC. 
This  was  done  by  microarray  analysis  (two  new  replicate  microarray  experiments  performed  and 
combined  with  previously  published  data  for  analysis),  live-dead  fluorescence  microscopy, 
quantitative real-time PCR, knock-out strain analyses, as well as traditional growth studies. In addition, 
a control and two isolates selected after growth in BC were genome sequenced using the 454 (Roche) 
sequencing platform. 
We  present  results  showing  that  exposure  to  BC  (25%  below  MIC)  selects  for  a  tolerant 
subpopulation  of  E.  coli  employing  both  BC  specific  and  general  stress  responses,  and  that  this 
subpopulation appears to have inheritable characteristics. 
2. Results and Discussion  
2.1. Morphological Changes and Cultivability as Analyzed by CFU after BC Exposure 
The original MIC of BC in TSB is about 12 µg/mL [18]. Growth of E. coli in the presence of a  
BC-concentration below MIC (9 µg/mL) was analyzed by plate counts and optical density (Figure 1A), 
and morphological changes visualized by BacLight live/dead fluorescence microscopy (Figure 1B). 
The addition of BC resulted in ~50% reduction of CFU/mL in the first 60 min and a total of ~98% 
reduction after 180 min. Exposure to BC also affected the morphology of the cells (filamentation).  
As  also  found  in  a  previous  study  [18],  the  cells  multiplied  at  a  rate  similar  to  the  control  after  
~300 min and the cells regained their original morphology after 360–420 min. 
To  exclude  the  possibility  that  regrowth  after  the  initial  kill  was  due  to  neutralization  of  BC, 
bacteria grown in BC to mid-exponential growth phase were re-inoculated in fresh medium with BC. 
The regrowth times of these cells were reduced by approx. 220 min compared to cells pre-grown in 
medium without BC (and similar to what was observed for stationary phase control cells inoculated in 
TSB  without  BC).  This  indicated  that  the  observed  growth  was  not  a  result  of  neutralization  of 
antibacterial action, but that the population of cells surviving exposure to BC differed from the original 
culture and showed higher tolerance. Regrowth of cells after the initial killing phase  was delayed 
(compared  to  direct  re-inoculation  from  BC)  if  the  cells  were  grown  for  1–4  transfers  in  
medium  without  BC,  but  still  shorter  (approx.  150  min)  than  for  control  cells  (approx.  280 min)  
inoculated in BC. 
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Figure 1. (A) Growth curves (CFU/mL and OD) and (B) BacLight pictures of E. coli cells 
exposed to BC (9 µg/mL) and control at 0 (stationary phase), 60, 120, 180, 240, 300, 360 
and  420  min  after  inoculation.  Open  symbols  represent  the  control,  closed  symbols 
represent cultures with BC. The arrows and numbers 1, 2, 3 and 4 refer to the sampling 
points used for real-time PCR experiments. 
 
2.2. Microarray Analyses 
Samples for microarray analyses were collected when the cells had regained exponential growth at a 
cell density of approx. 1 ×  10
8 CFU/mL (time point 4 in Figure 1). The data presented represents data Int. J. Mol. Sci. 2012, 13  4105 
 
 
from  two  new  microarray  hybridizations,  BC  9  µg/mL  versus  control  (no  BC)  (see  experimental 
Section 3.8) in addition to a previously published experiment where only three genes (b1171, osmB 
and ykfE (ivy)) were identified as significantly different (up regulated) in cells grown in the presence of 
BC (7 μg/mL and BC 9 μg/mL) [18]. These combined data were used to identify 41 genes showing 
significantly different levels of expression (FDR < 0.05) in BC (9 μg/mL) compared to the control 
(Table 1). Among these genes were the acrB efflux gene, the ompF and ompW outer membrane protein 
genes and several genes involved in osmotic- and/or oxidative stress, in addition to several genes with 
unknown function. Some of these genes were studied further by knock-out mutations and real-time 
PCR (see Section 2.4). Among those with unknown function was gene ykfE. This gene has previously 
been shown to be a strong inhibitor of C-type lysozyme and was correspondingly renamed ivy [19,20]. 
In addition to its enzymatic activity on the bacterial cell, lysozyme also possesses a non-enzymatic 
inactivation mechanism. The most likely mechanism for microbial activity of lysozyme is membrane 
disruption as observed for several other antimicrobial peptides, rather than enzymatic degradation of 
the bacterial murein layer [23]. It is therefore possible that gene ykfE may have a function in protecting 
the cell against cell damaging agents. 
Table 1. Genes significantly different (FDR < 0.05) in BC (9 µ g/mL) compared to the control 
(based on two new microarray experiments and data from a previous experiments [18]) and 
corresponding t-values, expression (log 2 compared to the control) and description. 
Function and 
Gene Name 
Log 2 
(BC/Control) 
Gene Description and References 
Efflux System 
acrB  0.9 
AcrAB-TolC efflux pump [24,25]. The acrB gene has previously been linked to BC 
resistance [8,12]. 
Osmotic and/or Oxidative Stress 
hdeA  1.6 
The hdeA gene encodes the acid stress chaperone HdeA that enhances survival in 
extreme acid conditions [26]. The hdeA gene has also been shown to be induced by 
sodium salicylate [27]. 
htrA (degP)  0.8 
Membrane-associated serine endoprotease (known heat shock protein that has also 
been shown to be induced by ampicillin and kanamycin in E. coli [28] and are 
hypothesized to participate in the degradation of oxidatively-damaged proteins 
localized in the cell envelope [29,30]. 
ompF  −1.7 
The OmpC and OmpF porins account for approx. 2% of the total protein content of the 
cell [31] and allow for the passive diffusion of solutes across the outer membrane. 
ompF has previously been shown to be regulated by changes in osmolarity [32] and in 
response to oxidative stress [27] and has been linked to BC resistance [13]. 
osmB  1.6 
osmB is a multistress-responsive gene and encodes an outer membrane lipoprotein of 
unknown function [33]. osmB is transcribed under the control of two independent 
promoters, one is responsible for the response to the growth phase and to osmotic 
shock, whereas the other is the target of response regulator RcsB [34] which is a 
positive regulatory gene for capsule (colanic acid) synthesis. 
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Table 1. Cont. 
Function and 
Gene Name 
Log 2 
(BC/Control) 
Gene Description and References 
Osmotic and/or Oxidative Stress 
pflB  1.1 
Pyruvate formate lyase I. Gene pflB has previously been shown to be induced by 
sodium salicylate [27]. 
rpoS  0.8 
The rpoS gene (σ
S) acts as the master regulator of stationary phase response and 
general stress response [35] and controls the expression of genes involved in (among 
others) osmotic- and oxidative stress [36]. 
yciD (ompW)  2.2 
Gene yciD (or ompW) encodes an outer membrane protein (OMP) and mutants that 
lacked the OmpW protein have been shown to be resistant to colicin S4 [37]. Studies 
on Vibrio alginolyticus [38] have shown the up regulation of an OmpW homolog in 
response to high osmolarity (NaCl) and it was hypothesized that OmpW might act as 
OmpC of E. coli in response to salinity stress. 
ybdQ (uspG)  1.1 
The ybdQ (or uspG) gene share homologies with UspA and have been shown to 
accumulate under various growth inhibitory conditions and induced by heat shock and 
may function as a universal stress protein [39]. Gene ybdQ has previously been shown 
to be up regulated in response to osmotic upshift in E. coli [40]. 
yfiD  2.0 
Glycine radical cofactor that can reactivate pyruvate formate lyase after oxidative 
stress. Gene yfiD has been shown to be up regulated during oxidative stress and was 
hypothesized to function in protecting bacterial cells from oxidative stress [41,42]. 
Other  
b2097 (fbaB)  1.0  Fructose 1,6-bisphosphate aldolase 
edd  −2.1  Phosphogluconate dehydratase 
eutH  −0.9  Putative integral membrane protein 
fruB  1.0  Fructosephosphotransferase enzyme III 
gntK  −3.3 
Genes gntKTU constitute the GntI system and metabolize gluconate via the  
Entner-Doudroff pathway [43]. gntT and gntU, encodes a high- and low- affinity 
gluconate transporters, respectively, and gntK, encode a  
thermo-resistant gluconokinase. 
gntT  −3.1   
gntU_1  −3.1   
hdhA  0.6  7-alpha-hydroxysteroid dehydrogenase 
lrhA  −1.0 
Gene lhrA encodes a LysR-type regulator LrhA [44] a new transcriptional key 
regulator of flagella, motility and chemotaxis genes in E. coli. LrhA is also shown to 
function as a regulatory component in the RpoS-dependent growth phase repression  
of ompF [45]. 
malZ  0.7  Maltodextrin glucosidase 
nagE  −0.6  N-acetylglucosamine-specific enzyme II of phosphotransferase system 
nirD  3.5  Nitrite reductase [NAD(P)H] subunit 
plsB  0.7  Glycerolphosphate acyltransferase activity 
rbsB  1.5  D-ribose binding protein, periplasmic 
rplN  −0.4  50S ribosomal subunit protein L14 
speB  −0.6  Agmatinase 
tktA  0.4  Transketolase; binds Zn(II) 
torS  −0.7  Sensor kinase for torCAD operon Int. J. Mol. Sci. 2012, 13  4107 
 
 
Table 1. Cont. 
Function and 
Gene Name 
Log2 
(BC/Control) 
Gene Description and References  
Other 
tpiA  0.8  Triosephosphate isomerase 
ybbU (allR)  0.7  Repressor for allantoin (all) and glyoxylate (gcl) utilization operons 
yecI (ftnB)  1.2  Ferritin-like protein, function unknown 
yhiW (gadW)  1.7  Positive AraC-type regulator of gadA and gadBC 
yihG  0.6  Characterized as poly(A) polymerase II, but this claim has been contradicted 
ykfE (ivy)  1.4 
The ykfE gene has previously been shown to be a strong inhibitor of  
C-type lysozyme and was correspondingly renamed ivy [19,20]. 
Unknown  
b1171  2.1 
Gene b1171 (or ymgD) has no known function and produced no hit on a Pubmed 
search. The protein sequence produced no close hits other than a 100% identity to a 
hypothetical protein in Shigella flexneri (BLAST). 
b2107  1.0  Function unknown 
b2295  0.5  Function unknown 
yaiL  0.8  Function unknown 
ybjX  0.6 
Gene ybjX has no known function but has 99% protein homology to a putative  
enzyme in Shigella flexneri 2a and 55% protein homology to a putative VirK  
protein in Salmonella enterica (180 identical of 330 amino acids) (BLAST). 
yieE  1.0  Function unknown 
yieF  0.8 
The yieE gene has no known function but showed 97% identity (246 identical of  
253 amino acids) to a hypothetical protein from Shigella flexneri and 77% identity 
(194 identical of 253 amino acids) to a putative cytoplasmic protein from  
Salmonella typhimurium (BLAST). 
Gene description is derived from the cited references and from EcoGene [46]. 
2.3. Susceptibility of Knock-out Mutants 
Based on difference in expression during regrowth in BC (Table 1) and availability, the role of 
selected genes was further investigated using single gene knock-out mutants and an expression strain. 
These were tested by MIC tests and regrowth tests. Regrowth time reflects the initial kill by BC and is 
defined  as  the  time  from  inoculation  to  the  time  where  the  cells  had  reached  their  initial  start 
concentration,  as  measured  by  increasing  CFU  and/or  OD  (although  it  cannot  be  excluded  that  a 
subpopulation is growing at an earlier stage). For calculation see Section 3.1. Only two (ompC and 
ybjX) of the 12 knock-out strains and one expression strain investigated (Table 2) showed altered 
regrowth time compared to the wild type when exposed to BC. Knock-out strain ybjX had a slight 
increase in regrowth time compared to the control (+ 120–150 min) and was therefore studied further 
in a growth competition study. The ompC strain had a faster regrowth (176.0 ±  22.2 min) compared to 
the wild type strain (254.7 ±  2.4 min) when log phase cells were used as inoculum. A delayed regrowth 
was also observed for knock-out strain b1171 but this was not reproducible. These observations are 
discussed further under Section 2.4. The MIC of BC was similar for the knock-out strains and the wild 
type strain. Knock-out strains b1171 and ybjX were studied further by real-time PCR and in a direct 
growth competition with the wild type by use of real-time PCR analysis (see Section 2.4). Int. J. Mol. Sci. 2012, 13  4108 
 
 
Table 2. Knock-out strains and expression strain used in this study. 
Strain  Knock-Out Strain Details 
a  Source or Reference 
MG1655  b1171::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  gntK::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  gntT::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  hdeA::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  lrhA::Tn5KAN-2  University of Wisconsin, Madison 
b 
MG1655  ompC::Tn5KAN  [47] 
MG1655  ompF::Tn5KAN  [47] 
MG1655  osmB::Tn5KAN-2  University of Wisconsin, Madison 
b 
MG1655  ybjX::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  yciD::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  yieF::Tn5KAN-I-SceI  University of Wisconsin, Madison 
b 
MG1655  ivy::KAN  [19] 
MG1655 
pAA410-arabinose-inducible Ivy 
overexpression strain 
[19] 
a KAN, kanamycin resistance; 
b E. coli Genome project [48]. Published by Deckers et al., 2004 [19]. 
2.4. Real-Time PCR Analyses 
Based on microarray- and knock-out strain results genes acrB, b1171, ompF and ybjX were studied 
further by real-time PCR experiments. Time points equivalent to sampling points 1–4 in Figure 1 were 
investigated. The early time points were chosen to investigate if the genes with altered expression 
during mid-logarithmic growth also were involved in the early response to BC. However, it cannot be 
excluded that the expression measured during these early time points could be a mixture of initial BC 
response and the transition from stationary growth phase to exponential growth phase. The cells grown 
in the presence of BC (9 µg/mL) were compared to non-stressed cells (see Section 3.5). The analyses 
showed that the investigated genes were also involved in the early response to BC. The expression of 
acrB in BC exposed cells was higher during the early time points than during the regrowth phase, with 
a  maximum  expression  (3.6  ±   0.2)  (log2  of  fold  change)  60  min  after  exposure.  The  expression 
stabilized to approx. 1.0 during the growth phase (Figure 2). A similar expression profile was observed 
for gene ybjX with maximum expression at 60 min (2.9 ±  0.5) but this gene did not seem to be up 
regulated during the growth phase. Gene b1171 was up regulated at all time points during BC exposure 
with the highest expression at 60  min (3.3). The expression of ompF declined after BC exposure  
and  was  lowest  at  60  min  (−3.1  ±   0.5)  and  appeared  to  stabilize  at  approx.  −1.6  during  the  
growth phase. 
The results from the real-time PCR analyses from mid-exponential growth phase (time point 4 
(Figure 1), OD~0.5) were also compared to previous microarray results (OD~0.5) [18]. The results 
showed that the real-time PCR results coincided well with the previous microarray results for genes 
acrB and ompF. Gene b1171 had a higher expression in the real-time PCR analyses, while gene ybjX 
had a lower expression. Both reference genes accD and gapA were used and gave similar results. 
   Int. J. Mol. Sci. 2012, 13  4109 
 
 
Figure 2. Real-time PCR results of Escherichia coli cells exposed to BC at 30 and 60 min, 
and  at  OD  0.1  and  0.5  after  inoculation  (equivalent  to  sampling  points  1,  2,  3  and  4, 
respectively,  shown  in  Figure  1).  The  expression  is  presented  as  log  2  of  fold  change 
compared to the reference gene, accD, and the control. The expression was based on 3 
biological replicates.  
 
Figure 3. Real-time PCR results from a competitive growth experiment of mixed cultures 
of knock-out strain b1171 and the wild type, and knock-out strain ybjX and the wild type. 
The time points used were equivalent to sampling points 1, 2, 3 and 4 shown in Figure 1. 
The log 2 of fold change was calculated using the ∆∆CT calculation based on gene accD 
and the kanamycin resistance gene related to the growth in the presence and absence of BC. 
The expression was based on 3 biological replicates.  
 
Based on the results from the knock-out mutant regrowth tests in BC and the above real-time PCR 
results, direct growth competition tests with the wild type were performed for knock-out strains b1171 
and ybjX. The direct growth competition (log 2 of expression between the reference gene (accD) and Int. J. Mol. Sci. 2012, 13  4110 
 
 
the kanamycin resistance gene (related to growth in the presence and absence of BC), showed that the 
ybjX knock-out strain had a slower growth compared to the wild type when exposed to BC (Figure 3). 
The growth of the b1171 knock-out strain in BC was not significantly different from the wild type.  
The gene expression analysis showed that during regrowth in BC, the cells had a higher expression 
of the acrB gene involved in the AcrAB-TolC efflux system [25] than the control cells. The acrB gene 
has previously been linked to BC resistance [8,12] and encodes an RND (resistance nodulation cell 
division)-type transporter, AcrB, that together with a periplasmic accessory protein AcrA and the TolC 
outer membrane channel composes the AcrAB-TolC multidrug efflux system in E. coli. The AcrAB 
efflux system removes antibiotics, and other lipophilic and amphiphilic inhibitors, from the cytoplasm, 
through the periplasm, directly to the external media [24,25,49]. The acrB gene was not up regulated 
during growth in any of the other stress conditions [18] and we therefore believe that AcrAB-TolC 
contribute to survival in BC by removing BC from the cytoplasm.  
Gene ybjX was highly expressed at 30 and 60 min after exposure to BC and knock-out analyses 
(direct competition growth) showed that the ybjX knock-out strain had impaired survival compared to 
the wild type when exposed to BC. This gene has no known function in E. coli, but showed protein 
homology to somA (S.t.) and virK (S.f.) Salmonella entericia. The virK gene has previously been 
shown to confer resistance to the cationic peptide polymyxin B, probably by contributing to remodeling 
of the bacterial outer membrane [50]. It is therefore possible that gene ybjX has a similar role of 
remodeling the bacterial cell envelope in response to BC in E. coli. 
Several of the genes that showed changed expression (microarray results) during growth in BC 
(hdeA, htrA (degP), ompF, ompW, osmB, pflB, rpoS, ybdQ (uspG) and yfiD) (see Table 1 and Figure 2) 
have previously been associated to osmotic- and oxidative stress. This coincides with the results from 
our previous study where E. coli cells pre-cultivated in the presence of the oxidative agent salicylate 
resulted in higher MIC of BC [9]. The ompF gene was down regulated in response to BC and has 
previously been linked to BC resistance as well as osmotic- and oxidative stress [13,27,51]. The ompW 
(yciD) gene was up regulated and it has been hypothesized that OmpW might act as OmpC of E. coli 
in response to salinity stress [38]. OmpF and OmpC are major constituents of the outer membrane and 
are involved in osmoregulation of the cell. At low osmolarity, OmpF predominates, while at high 
osmolarity OmpC replaces the OmpF due to the larger pore and faster flow rate in OmpF compared to 
OmpC [52]. It is also known that the permeability to antimicrobial agents through the outer membrane 
in  E.  coli  greatly  depends  on  the  contents  of  OmpF  and  OmpC  porin  proteins,  and  that  OmpF 
deficiency  makes  cells  resistant  to  some  antibiotics  [53–55].  Low  concentrations  of  QACs  have 
previously  been  shown  to  damage  the  outer  membrane  and  result  in  the  loss  of  many  of  its 
osmoregulatory functions [2,56]. The fact that the ompF knock-out strain did not show an increase in 
BC  tolerance  indicates  that  the  observed  down  regulation  of  ompF  was  a  response  to  increased 
osmolarity and not a result of preventing BC entering the cytoplasm through OmpF (as is the case for 
ampicillin [47,57]). This hypothesis was strengthened by the fact that the ompC knock-out strain (log 
phase) had an increased tolerance to BC, theoretically resulting in decreased expression of ompF as a 
response to increased osmolarity in addition to absence of OmpC [52].  
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2.5. Osmotic- and Oxidative Stress 
In a previous study [9], we showed that exposure to compounds such as salicylate and methyl 
viologen resulted in  increased MIC of BC but  no molecular studies  were performed. The  genetic 
response obtained in the present study support that common mechanisms are involved in protection 
against BC and osmotic or oxidative stress. To confirm previous findings and test the association with 
osmotic stress, growth in BC for cells pre-grown in the presence of 0.5 M and 0.77 M (4.5%) sodium 
chloride (NaCl): 5 mM and 10 mM salicylic acid (SAL) and 0.1 mM and 0.2 mM methyl viologen 
(MV) was tested. For all three compounds, the regrowth time in BC was reduced compared to cells 
pre-grown in pure TSB (Figure 4).  
Figure 4. Regrowth time in BC (min) for cells pre-grown in osmotic and oxidative stress; 
NaCl  (sodium  chloride),  SAL  (salicylic  acid),  MV  (methyl  viologen).  0  M  is  the  non  
pre-exposed control.  
 
2.6. Characteristics of BC Isolates 
To investigate if the surviving subpopulation after BC exposure was a homogeneous population, a 
screening of 94 colonies selected after regrowth in BC were screened in Bioscreen for BC tolerance 
(see Section 3.11). The results showed that approx. 10% of the isolates grew better in BC than the non 
pre-exposed control while the remaining colonies has similar growth as the control. This indicated that 
the subpopulation consisted of a heterogeneous group. The two isolates with the fastest regrowth in BC 
compared to the control (M95 and M100) were studied further for growth in BC (see Figure 5) and 
selected for genome sequencing to look for common mutations. The two isolates had smaller colony 
morphology on TSA but had similar growth in TSB as the control. At 15 µg/mL BC the reduction in 
time of regrowth compared to the control was −306 and −236.7 min for M95 and M100, respectively. 
The isolates were also tested for maintenance of tolerance after ten repetitive overnight inoculations in 
medium without BC (more than 100 generations). The isolates maintained their tolerance to BC. Two 
random small colony variants from the control were also tested. These did not show any increased 
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tolerance to BC, indicating that the small colony morphology itself was not responsible for increased 
BC tolerance.  
Figure 5. Growth curves (OD—log scale) of the Control (circle symbols), M95 (square 
symbols) and M100 (triangle symbols) in Bioscreen exposed to BC (0, 11, 12, 13, 14 and 
15 µg/mL). The vertical bars represent the standard deviation of the ten replicates (10 wells 
per sample and concentration).  
 
Genome sequencing: Genome sequencing of the control and the two BC selected isolates (M95 and 
M100)  revealed  three  single  point  mutations  (in  the  control,  M95  and  M100),  compared  to  the 
reference genome (E. coli U00096), leading to an amino acid substitution, in genes kdpD, hcp and one 
single point mutation in a non-coding region. A single point mutation in gene rpsA (nucleotide position 
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795  in  the  rpsA  gene;  T→G)  leading  to  an  amino  acid  substitution  (Asp-265→Glu)  was  found 
exclusively in one of the BC exposed isolates (M95) (15×  coverage) (see Table 3). 
Table 3. Single point mutations identified in the Control, M95 and M100 when assembled 
with the E. coli U00096 reference genome. 
Allele Variation 
Single Point Mutations (+/−)  Reference 
Position 
Gene Annotations 
Amino Acid 
Substitution  Control  M95  M100 
G→T  +  + 
a  + 
a  720994  Gene: kdpD  Gln→Lys 
A→G  + 
a  +  +  911614  Gene: hcp  Leu→Pro 
C→T  +  + 
a  +  3957957  No coding region  - 
T→G  − 
b  +  − 
b  962012  Gene: rpsA  Asp→Glu 
a The single point mutations were not reported when using default parameters, but were verified by visual 
inspection (the lowest coverage was seven); 
b Visual inspection confirmed the absence of the single point 
mutation in the Control and M100. This was also verified by sequencing. 
Ribosomal protein S1, the product of the essential rpsA gene, consists of six imperfect repeats of the 
same motif. The mutation was not in the S1 RNA binding domain. The total coverage was 13.5 for the 
Control, 11.6 for M95 and 12.3 for M100 given an average read length of 374.4 bp. The mutation was 
verified by PCR and sequencing part of the rpsA gene (position 683–988) in the control, M95 and 
M100. In addition, part of the rpsA gene in ten other isolates (seven that grew faster than the control 
and  three  that  grew  slower)  selected  after  growth  in  BC  was  sequenced.  None  of  these  had  any 
mutation. The RpsA protein is a target site for antimicrobial agents in the tetracycline class [58] as 
well  as  other  antibacterial  agents  that  inhibit  the  elongation  process  during  bacterial  protein  
synthesis [59,60]. The fact that the point mutation was observed in only one of the BC selected isolates, 
several  isolates  still  had  a  higher  tolerance  to  BC  and  showed  altered  phenotypic  characteristics 
compared  to  the  control,  indicates  that  there  are  other  additional  mechanisms  responsible  for  the 
observed tolerance to BC.  
Based on the survival rate, the characteristics of isolates selected after BC exposure and the genome 
sequencing of a control and two BC exposed isolates, it is likely that BC concentrations below MIC 
(25% below MIC) select for phenotypic variants in a sensitive culture with the ability to survive and 
grow in BC. Comparable studies in  Pseudomonas, although using a longer exposure period, have 
suggested that concentrations of BC below MIC are sufficient to select for adapted variants in sensitive 
cultures. Sub-inhibitory concentrations of BC (increasing at two-generation intervals) were shown to 
select for spontaneous variants of Pseudomonas aeruginosa grown in long-term (792 h) continuous 
culture [22] and adaptation over time (24 h and 96 h biofilm) of Pseudomonas fluorescens in biofilms 
to low levels of BC (10 µg/mL–50% below MIC) has been suggested by Dynes et al. (2009) [21]. This 
study shows that even short exposure to concentrations of BC allowing growth can select for BC 
tolerant variants of E. coli. The genome sequenced isolates maintained their tolerance to BC for more 
than  100  generations  and  re-inoculation  study  of  the  whole  sub-population  showed  that  the  cells 
maintained some level of tolerance even after repetitive passages in medium without BC (approx.  
13  generations).  This  maintenance  of  tolerance  cannot  solely  be  explained  by  the  initial  
biomolecular-  and/or  gene expression stress  response and  appeared to  be dependent  on the initial Int. J. Mol. Sci. 2012, 13  4114 
 
 
selection of a subpopulation. Nor did the genome sequence of the BC isolates reveal any common 
mutation explaining the inheritable BC tolerance. 
3. Experimental Section  
3.1. Strains and Growth Conditions 
The Escherichia coli strain used in this study was the genome-sequenced strain K12 MG1655 [61]. 
Bacteria were grown on tryptone soya agar (TSA, Oxoid) overnight at 37 C. Cultures were prepared 
by inoculating one colony from TSA to 5 mL tryptone soya broth (TSB, Oxoid), incubation overnight 
at 37 C, shaking at 200 rpm. This culture was initially diluted 1:10 and used to inoculate TSB with or 
without BC (dilutions from 50% BC stock solution, Norwegian pharmaceutical depot) (40–50 mL total 
volume) to a final concentration of approx. 1 ×  10
7 CFU/mL (1:100 dilution of overnight culture). The 
BC concentrations used in all experiments was 9 μg/mL (25% below MIC), except in the selection of 
isolates for genome sequencing, where the concentration was higher, 11.5 μg/mL, due to a new batch 
of BC (the stock solution used has a concentration of approximately 50% (that is 5 ×  10
5 µg/mL) 
according  to  the  manufacturer).  The  regrowth  time  was  nevertheless  the  same  as  for  previous 
experiments using 9 µg/mL BC. In the Bioscreen experiments testing the two isolates chosen for 
genome sequencing, the BC concentrations were 11–15 µg/mL due to the new BC batch and the fact 
that the cells were less susceptible to BC during growth in Bioscreen plates (probably due to the smaller 
volume and difference in shaking regime). The lowest concentration of BC totally preventing growth 
after 24 h (the minimal inhibitory concentration) in TSB was 12 μg/mL, as also shown previously [18], 
using approx. 1 ×  10
7  CFU/mL (1:100 dilution of overnight  culture) as inoculum. The knock-out 
strains (containing a kanamycin resistance selection gene) (Table 2), were grown overnight at 37 C on 
TSA containing 50 μg/mL kanamycin (Sigma). The arabinose-inducible expression strain (ivy) (Table 2) 
was  grown  overnight  at  37  C  on  TSA  containing  100  μg/mL  ampicillin  (Sigma)  and  50  μg/mL 
kanamycin. Induction of ivy was performed by adding 0.2% (w/v) L-(+)-arabinose (Sigma) at an optic 
density (OD600) of approx. 0.2. The cells were then grown to an OD of approx. 0.5 before 5 mL of this 
culture  was  used  to  inoculate  45  mL  TSB  containing  BC  and  0.2%  (w/v)  arabinose.  Growth 
experiments were performed with and without arabinose induction. The wild type was used as the 
control and grown under similar conditions as the expression strain. 
The regrowth time reflects the initial killing and was defined as the time from inoculation to the 
time where the cells had reached their initial start concentration as measured by CFU and/or OD and 
estimated to be the time point where the linear regression line (Y = aX + b) equaled the optical density 
(OD600) at time zero (OD at time zero = aX + b). The linear regression line was based on three points 
in the linear area of the OD curve.  
3.2. BacLight Live-Dead Fluorescence Microscopy 
A 1 mL bacterial culture was centrifuged at 10,000g at 4 C in a micro centrifuge for seven min. 
The supernatant was removed and the cells resuspended in 1 mL of filter sterilized peptone water. This 
suspension was diluted to give approximately 1 ×  10
7 CFU/mL, and 0.5 mL of this dilution mixed with 
0.5 mL of the BacLight (Molecular Probes) mixture (BacLight ampoules mixed in 5 mL of filter Int. J. Mol. Sci. 2012, 13  4115 
 
 
sterilized water). The BacLight/cell mixture was incubated for 15 min in the dark at 4 C before being 
filtered down on a 0.22 micron, black polycarbonate filter (Osmonics Inc.). The filter was washed 
twice with 1 mL filter sterilized peptone water and then viewed by fluorescence microscopy (Leica 
DMLB  microscope)  using  a  RT  color  spot  camera  (Mode  2.2.0;  Diagnostic  Instruments,  Inc.: 
Burroughs, Mich., USA) [62] and Spot Advanced software (version 3.0; Meyer Instruments: Houston, 
Tex., USA) [63]. 
3.3. RNA Extraction 
Total RNA was extracted using the RNeasy Protect Bacteria Mini Prep kit (Qiagen) as recommended 
by the manufacturer including the ―on-column‖ DNase treatment. The concentration and purity of the 
total RNA was analyzed using NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Inc.).  
3.4. Reverse Transcription 
Total RNA was reverse transcribed by using random primers. Reaction mixture (20 μL) contained 
300 ng of total RNA, 100 ng random primers (Invitrogen) and 1 μL 10 mM dNTP mix in a reaction 
volume of 13 μL was denatured at 65 C for 5 min, snap cooled on ice and centrifuged briefly. The 
reaction mix was left at room temperature for 10 min to allow the random primers to anneal to the 
template. Then 4 μL 5×  First Strand buffer (Invitrogen), 2 μL 0.1 M DTT was added and the reaction 
mix was incubated at 42C for two min before 1 μL (200 U/μL) SuperScript II reverse transcriptase 
(Invitrogen) was added. The labeling reaction was incubated at 42 C for 50 min. The reaction mix was 
centrifuged briefly and incubated at 70 C for 15 min before centrifuged briefly again. Two reverse 
transcriptase reactions were made for each biological replicate of RNA in addition to one negative 
control (without enzyme). After the reverse transcriptase reaction, the cDNA was added, 20 μL water, 
and 2 μL of this was used as template in the quantitative real-time PCR analyses.  
3.5. Quantitative Real-time PCR  
The expression of genes acrB, b1171, ompF and ybjX were analyzed at 4 different time points 
(Figure 1) after inoculation in medium with and without BC (9 µg/mL); 30 and 60 min and at an OD600 
of approximately 0.1 and 0.5. Different time points for the ∆CT(control) (see data analysis) were used to 
calculate the CT(BC) at the 4 different time points. For time points 30 and 60 min, the values from the 
control sample at time 0 was used while the values from the control sample at OD~0.1 and OD~0.5 
were used for the corresponding optical densities for cells grown in the presence of BC. The selection 
of the reference genes (accD and gapA) was based on the previous microarray experiment on various 
stress conditions [18] with the criteria that these genes did not change significantly compared to the 
control during the 11 stress conditions tested. In the time course experiments only gene accD was used 
as  a  reference  gene,  since  the  gapA  reference  gene  was  not  an  optimal  choice  when  measuring 
expression during both the non-growth and growth phases.  
Primers and TaqMan
® probes (MGB) (Table 4) were designed using Primer Express software ABI 
PRISM
® software (version 1.0; Applied Biosystems: Foster city, CA, USA) [64]. The probe contained 
FAM  (6-carboxyfluorescein)  as  fluorescent  reporter  dye  covalently  linked  to  the  5'end,  and  a  Int. J. Mol. Sci. 2012, 13  4116 
 
 
non-fluorescent quencher (NFQ) was covalently linked close to the 3' end. The reporter signal was 
normalized to the emission of an internal reference dye (ROX-6-carboxy-X-rhodamine). 
Table 4. Primers and fluorogenic probes for real-time PCR analyses. 
Gene  Probe or Primers  Sequence (5'-3')  Denaturation Temp. (C) 
accD 
probe  CGCAGTGAATTCC  70 
forward primer  TGCCGCCTGGATTCCA  59 
reverse primer  GTCGATCGCGCCTTTCTC  58 
gapA 
probe  CGAAACTGCTCGTAAAC  69 
forward primer  AAGCAACTGGTCTGTTCCTGACT  58 
reverse primer  TTCGCACCAGCGGTGAT  58 
acrB 
probe  TGCGATGGTTTTCG  69 
forward primer  GCGCTTTCTCGCAAATCAA  59 
reverse primer  CGATTGCGGGCAGGTTAA  59 
ybjX 
probe  CATCGCCGTAGTTTT  68 
forward primer  TCGGCCGGGTAAATTCTG  58 
reverse primer  CGAGCGCAGCAAAAATTTCT  59 
b1171_ymgD 
probe  CCCGCAAATGC  68 
forward primer  ACTGAATCAGGTTTGCGCTAAAG  59 
reverse primer  TCATCAATTGCCGTGATCAAC  58 
ompF 
probe  ACCTGGGTAAAAACGA  68 
forward primer  TGGCCTGAACTTCGCTGTT  58 
reverse primer  GAACGGCGTGCAGTGTCA  59 
KAN 
probe  TGCGCCGGTTGC  69 
forward primer  TTGATGCGCTGGCAGTGT  58 
reverse primer  GGACAATTACAAACAGGAATCGAA  58 
All probes were MGB probes (5' label: 6FAM and 3' label: MGBNFQ (Minor groove binder/Non-fluorescent quencher). 
Amplification  reaction  mixture  (25  μL)  contained  2  μL  template  (cDNA)  or  20  ng  DNA;  
1×   TaqMan  buffer  A;  5  mM  MgCl2,  200  μM  each  of  dATP,  dCTP,  dGTP  and  dUTP;  80  μM 
AmpErase uracil N-glycosylase; 0.2 μM forward/reverse primer; 0.1 μM MGB probe; 1.25 U AmpliTaq 
Gold DNA polymerase (Applied Biosystems). Before amplification, the reaction mixture was heated to 
50 C for two min and then denatured at 95 C for 10 min. The amplification profile was as follows: 
40 cycles of 95 C for 15 s and then 60 C for one min. Reactions were performed in the Abi Prism 
7900HT Sequence Detection System (Applied Biosystems). Reaction conditions were programmed 
and data were analyzed using the SDS software (version 2.2; Applied Biosystems: Foster City, CA, 
USA, 2003).  
3.6. DNA Extraction 
DNA was extracted using the DNeasy Tissue Kit (Qiagen). Briefly, 100–1000 μL bacteria was 
centrifuged at 5000 g for 10 min at 4 C. The supernatant was discarded and the pellet was frozen at 
−20  C  for  later  DNA  purification.  The  manufacture  protocol  was  followed  from  this  point.  The 
concentration  and  purity  of  the  DNA  was  analyzed  using  NanoDrop  ND-1000  spectrophotometer Int. J. Mol. Sci. 2012, 13  4117 
 
 
(NanoDrop Technologies, Inc.) and 20 ng of DNA was used as template in the quantitative real-time 
PCR analyses. 
3.7. Knock-out Strain Analyses 
Knock-out strains and the expression strain were tested for altered regrowth time compared to the 
wild type after exposure to BC (and absence of BC). A diluted overnight culture (as described in 
strains and conditions) was used as inoculum in all experiments. In addition, the ompC and ompF 
knock-out strains were inoculated with log phase cells (OD600 approx. 0.5 (1 ×  10
8 CFU/mL)). Two of 
the knock-out strains (b1171 and ybjX) were also selected for competitive growth with the wild type 
strain in the presence and absence of BC using quantitative real-time PCR (see Section 3.5). The wild 
type and the selected knock-out strains were combined in equal amounts (mixed culture) and samples 
were collected for purification of DNA at time zero (before addition of BC), at 30 min after exposure and 
at the optical density (OD600) of approx. 0.1 and 0.5. The two first time points were selected to capture 
the initial stress response to BC while the next two time points were selected to analyze initial growth 
(approx. 1 ×  10
7 CFU/mL) and mid-exponential growth (approx. 1 ×  10
8 CFU/mL), respectively. The 
method was based on the change in a reference gene, accD, versus the kanamycin resistance gene 
(KAN) inserted into the knock-out strains using the CT calculation (User Bulletin #2: ABI PRISM 
7700  Sequence  Detection  System).  In  this  calculation  CT  =  [CT(BC)  −  CT(Control)],  where  
CT = CT(KAN) − CT(accD) (BC = presence of BC and Control = absence of BC). 
3.8. Data Analysis 
Microarray data from cells exposed to BC (7 and 9 μg/mL) (previously published data set [18]) was 
used to create gene lists of the 50 genes with lowest false discovery value (FDR) from BC (7 μg/mL), 
BC (9 μg/mL) and BC (7 and 9 μg/mL). In addition, two new replicate microarray hybridizations  
were performed (direct comparison between the control and BC (9 μg/mL)) (method as previously 
described [18]) identified 19 genes that were either up- or down regulated compared to the control. 
These new 19 genes were combined with the other 50 genes to generate a new gene list of 69 genes. 
These  genes  were  present  in  all  the  observations  (hybridizations)  from  the  previous  microarray 
experiments [18]. These 69 genes were used as responses in a new 50–50 MANOVA analysis of the 
stress experiment previously described [18] and resulted in 41 genes, showing a statistically significant 
(FDR < 0.05) difference in expression level between BC (9 μg/mL) and the control (Table 1). This list 
of significant genes was used to select genes for knock-out analyses and real-time PCR analyses. The 
CT  calculation  (User  Bulletin  #2:  ABI  PRISM  7700  Sequence  Detection  System)  was  used  to 
calculate the changes in gene expression compared to the reference genes (accD and gapA) and the 
control sample (CT = [CT(BC) − CT(control)], where CT = CT(test gene) − CT(reference gene)). The expression 
is reported as log 2 of fold change (2
−CT). For the CT calculation to be valid, the efficiency of the 
target amplification and the efficiency of the reference amplification must be approximately equal. 
This was tested and all primer/probe pairs had an amplification effect higher than 95%.  
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3.9. Pre-Exposure to Osmotic- and Oxidative Stress Experiments 
Cells were exposed to 0.5 M and 0.77 M sodium chloride (NaCl): 5 mM and 10 mM salicylic acid 
(SAL) and 0.1 mM and 0.2 mM methyl viologen (MV) to simulate osmotic- and oxidative stress.  
The  cells  were  inoculated  as  described  in  strains  and  growth  conditions  and  grown  to  approx.  
1  ×  10
8  CFU/mL  before  being  inoculated  to  fresh  medium  (containing  BC)  (1:10  dilution  of the 
inoculation culture). The results are presented as the observed regrowth time in BC.  
3.10. Genome Sequencing (454 (Roche) Sequencing Platform) 
Selection of isolates: Cells exposed to 11.5 µ g/mL BC (resulting in same regrowth time as previously 
using 9 µg/mL) were grown to OD~0.5 and dilutions were plated on TSA and incubated overnight at 
37 °C . From these plates 94 individual colonies were picked (in addition to 3 colonies from the control 
grown  without  BC  and  3  negative  controls  (medium  only))  and  transferred  to  a  100  well-format 
Bioscreen C (MTX Lab Systems, Inc.) (350 μL TSB total volume) for overnight growth at 37 °C  with 
shaking. Cultures from this plate were initially diluted 1:10 and used to inoculate TSB without or with 
BC  (12  µg/mL)  in  2  new  100  well-format  plates  for  growth  and  on-line  turbidity  measurement  
(10 wells per sample and concentration). Based on the results, glycerol stocks were prepared for a 
selection of the 94 colonies and stored at −80 °C . One control sample (Control) and two samples from 
growth in BC (M95 and M100) were tested again for growth in BC before being selected for genome 
sequencing. A small amount from the freeze stocks were plated on TSA for overnight growth at 37 °C . 
One colony from each sample were transferred to 5 mL TSB and grown at 37 °C  overnight and tested 
for growth in Bioscreen (5 different BC concentrations 11, 12, 13, 14 and 15 µg/mL (all concentrations 
were below MIC in Bioscreen using a new batch of BC)). There were 10 replicate wells per isolate and 
BC concentration. DNA was purified from the overnight growth in TSB using the Qiagen Blood and 
Tissue kit (Qiagen). Briefly, 2 ×  500 μL bacteria were centrifuged at 5000 g for 10 min at 4 C. The 
supernatant  was  discarded  and  the  pellet  was  frozen  at  −80  C  for  later  DNA  purification.  The 
manufacture protocol for gram-positive bacteria was used in addition to lysozyme in the pretreatment 
buffer and an RNase step. The concentration and purity of the DNA was analyzed using NanoDrop 
ND-1000 spectrophotometer (NanoDrop Technologies, Inc.) in addition to EtBr-stained 1% agarose gel 
containing 500 ng of each sample. The DNA was sent to the Norwegian High-Throughput Sequencing 
Centre (NSC) (University of Oslo) for genome sequencing using the 454 (Roche) sequencing platform.  
Data analysis: The sequence reads were assembled and analyzed using the CLC Genomic Workbench 
software (version 3.7.1; CLC Bio.: Aarhus, Denmark, 2010). The three isolates, Control, M95 and 
M100, were all assembled against the E. coli U00096 reference genome. The SNP Detection tool 
(using default parameters) was then used to search for single point mutations.  
4. Conclusions 
There are most likely several interacting mechanisms involved in the response to BC at concentrations 
allowing growth, both BC specific and general stress related, and the apparent inheritance of tolerance 
to BC in E. coli. In summary, we have shown that exposure to a BC concentration 25% below MIC in 
nutrient medium results in initial killing of 95–99% of the cells followed by regrowth of a more BC Int. J. Mol. Sci. 2012, 13  4119 
 
 
tolerant subpopulation of E. coli in a sensitive culture and that this tolerance is partly inheritable.  
To  withstand  BC  during  regrowth,  genes  responsible  for  removing  BC  from  the  cytoplasm,  the  
AcrAB-TolC efflux system, and genes involved in maintenance of the outer membrane in response to 
increased  osmotic-  and  oxidative  stress  are  important.  Genome  sequencing  of  a  control  and  two 
selected isolates showing increased BC-tolerance after growth in concentrations of BC 25% below 
MIC identified no common point mutations in the BC tolerant isolates. One point mutation in gene 
rpsA (Ribosomal protein S1) was observed in one of the isolates. The observed tolerance can therefore 
not  solely  be  explained  by  the  observed  point  mutation.  Further  work  is  needed  to  address  the 
mechanisms behind the inheritance of tolerance to BC and the possible role of the observed single 
point mutation in gene rpsA. 
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